91 related articles for article (PubMed ID: 15317405)
21. Cost consequence analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery in Belgium.
Annemans L; Minjoulat-Rey MC; De Knock M; Vranckx K; Czarka M; Gabriel S; Haentjens P
Acta Clin Belg; 2004; 59(6):346-57. PubMed ID: 15819379
[TBL] [Abstract][Full Text] [Related]
22. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.
Turpie AG; Bauer KA; Eriksson BI; Lassen MR
Arch Intern Med; 2002 Sep; 162(16):1833-40. PubMed ID: 12196081
[TBL] [Abstract][Full Text] [Related]
23. Pharmacoeconomics of thrombosis management.
Hawkins D
Pharmacotherapy; 2004 Jul; 24(7 Pt 2):95S-99S. PubMed ID: 15317405
[TBL] [Abstract][Full Text] [Related]
24. Economic considerations in the prevention and treatment of venous thromboembolism.
Hawkins D
Am J Health Syst Pharm; 2004 Dec; 61(23 Suppl 7):S18-21. PubMed ID: 15597575
[TBL] [Abstract][Full Text] [Related]
25. Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery.
Tran AH; Lee G
Ann Pharmacother; 2003 Nov; 37(11):1632-43. PubMed ID: 14565815
[TBL] [Abstract][Full Text] [Related]
26. Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.
Nutescu EA
Am J Health Syst Pharm; 2007 Jun; 64(11 Suppl 7):S5-13. PubMed ID: 17519445
[TBL] [Abstract][Full Text] [Related]
27. Fondaparinux sodium: a review of its use in the prevention of venous thromboembolism following major orthopaedic surgery.
Reynolds NA; Perry CM; Scott LJ
Drugs; 2004; 64(14):1575-96. PubMed ID: 15233593
[TBL] [Abstract][Full Text] [Related]
28. Pentasaccharides in the prophylaxis and treatment of venous thromboembolism: a systematic review.
Nijkeuter M; Huisman MV
Curr Opin Pulm Med; 2004 Sep; 10(5):338-44. PubMed ID: 15316429
[TBL] [Abstract][Full Text] [Related]
29. [Cost-effectiveness analysis of enoxaparin for the prophylaxis of venous thromboembolism in major orthopedic surgery patients].
Brosa Riestra M; Rubio-Terrés C; Nadipelli V; Casado Collado A; Martínez Brotons F
Farm Hosp; 2003; 27(4):210-8. PubMed ID: 12966450
[TBL] [Abstract][Full Text] [Related]
30. Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery.
Sullivan SD; Kahn SR; Davidson BL; Borris L; Bossuyt P; Raskob G
Pharmacoeconomics; 2003; 21(7):477-96. PubMed ID: 12696988
[TBL] [Abstract][Full Text] [Related]
31. The pharmacoeconomics of deep vein thrombosis treatment.
Shorr AF
Am J Med; 2007 Oct; 120(10 Suppl 2):S35-41. PubMed ID: 17916458
[TBL] [Abstract][Full Text] [Related]
32. Evidence for extended prophylaxis in the setting of orthopedic surgery.
Dobesh PP
Pharmacotherapy; 2004 Jul; 24(7 Pt 2):73S-81S. PubMed ID: 15317402
[TBL] [Abstract][Full Text] [Related]
33. The design of venous thromboembolism prophylaxis trials: fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery.
Turpie AG
Int J Clin Pract; 2004 May; 58(5):483-93. PubMed ID: 15206506
[TBL] [Abstract][Full Text] [Related]
34. Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery.
Bergqvist D
Vasc Health Risk Manag; 2006; 2(4):365-70. PubMed ID: 17323590
[TBL] [Abstract][Full Text] [Related]
35. Prophylaxis against venous thromboembolism in orthopedic surgery.
Liu LT; Ma BT
Chin J Traumatol; 2006 Aug; 9(4):249-56. PubMed ID: 16849000
[TBL] [Abstract][Full Text] [Related]
36. [Standards and perspectives for thromboembolism prophylaxis].
Rader CP
Orthopade; 2007 Jun; 36(6):560, 562-6. PubMed ID: 17546440
[TBL] [Abstract][Full Text] [Related]
37. Choosing the appropriate antithrombotic agent for the prevention and treatment of VTE: a case-based approach.
Nutescu EA; Wittkowsky AK; Dobesh PP; Hawkins DW; Dager WE
Ann Pharmacother; 2006 Sep; 40(9):1558-71. PubMed ID: 16912250
[TBL] [Abstract][Full Text] [Related]
38. Cost considerations surrounding current and future anticoagulant therapies.
Fang MC; Minichiello T; Auerbach AD
Cleve Clin J Med; 2005 Apr; 72 Suppl 1():S43-9. PubMed ID: 15853179
[TBL] [Abstract][Full Text] [Related]
39. Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism.
Bauer KA; Eriksson BI; Lassen MR; Turpie AG
Curr Opin Pulm Med; 2002 Sep; 8(5):398-404. PubMed ID: 12172443
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
